Epigenetic antifibrotic effect of expression of long non-coding RNAs GAS5, MEG8, FLRL2 on the development of fibrosis in metabolic dysfunction-associated steatotic liver disease: systematic review
Background. Metabolic dysfunction-associated steatotic liver disease (MASLD) — and its progressive inflammatory stage, metabolic dysfunction-associated steatohepatitis (MASH) — has emerged as one of the most frequent causes of liver fibrosis. In the context of MASLD, fibrogenesis is governed by a highly complex interpl...